Gallant Sara C, Fritz Mark A, Paul Benjamin C, Costantino Peter D
Department of Otolaryngology, New York University, New York, New York, U.S.A.
Laryngoscope. 2015 Mar;125(3):604-7. doi: 10.1002/lary.24841. Epub 2014 Jul 14.
The risk of hemorrhage after therapeutic administration of tissue plasminogen activator (tPA) is well known. Cases of postadministration hemorrhage have been reported within many organ systems. We present a case of a 62-year-old female with undiagnosed thyroid goiter who received tPA for acute ischemic stroke and developed acute airway compromise. The surgical airway response team was called due to inability to ventilate or intubate. An incision into the mass during attempted tracheotomy released colloid and blood, decompressing the airway and facilitating ventilation and intubation. Hemithyroidectomy for mass removal was delayed for 3 days to allow normalization of post-tPA coagulopathy.
组织型纤溶酶原激活剂(tPA)治疗后出血的风险是众所周知的。给药后许多器官系统都曾报告过出血病例。我们报告一例62岁女性,患有未确诊的甲状腺肿,因急性缺血性卒中接受tPA治疗后出现急性气道受压。由于无法进行通气或插管,呼叫了手术气道反应小组。在尝试气管切开术时,切开肿块释放出胶体和血液,使气道减压并便于通气和插管。因tPA治疗后凝血功能障碍需要恢复正常,肿块切除的半甲状腺切除术推迟了3天。